Wired for Danger: Unveiling the Neural Secrets of Melanoma Metastasis
Professor Dominique Durand's team found that nerve activity recorded inside melanomas in mice could distinguish tumours that spread spontaneously from those with low metastatic potential.
Read the original paper
Melanoma, though it accounts for only a small percentage of skin cancers, is responsible for the majority of skin cancer deaths. With the number of melanoma cases rising sharply in recent years, early detection is becoming increasingly critical. While current methods rely on visual examinations and advanced imaging techniques, there’s a growing interest in understanding the role of the nervous system in cancer development. Surprisingly, tumors have their own network of nerves, and these nerves might be key to unlocking new ways to predict how dangerous a melanoma can become.
Understanding the intricate behaviors of tumors has long been a focus for cancer researchers. Recent findings from Case Western Reserve University reveal a breakthrough in differentiating between melanomas based on their metastatic potential through neural recordings. The research, led by Dr. Grant McCallum and Professor Dominique Durand, along with Jay Shiralkar and Tiana Anthony, uncovers how the neural activity within tumors correlates with their metastatic behavior. Their study, published in PLOS ONE, marks a significant step toward early detection and treatment of melanoma.
The researchers conducted a series of experiments on mice to observe the neural patterns in metastasizing and non-metastasizing melanomas. Professor Durand explained the motivation behind the study: “Our goal was to determine if the bioelectric behavior of tumors could serve as an early indicator of their metastatic potential.”
To explore the differences in neural activity between various types of melanomas, the research team used a combination of advanced neural recording techniques and bioluminescent imaging. They implanted electrodes in the tumors of mice to monitor neural spikes, providing a real-time look at the electrical activity within the tumors. This allowed the team to capture detailed neural patterns and correlate them with the tumors’ behavior over time. Daily recordings were taken to ensure that the data reflected the ongoing changes within the tumor environment.
The team discovered that melanomas with high metastatic potential exhibited significantly higher neural activity compared to those with low metastatic potential. This activity was particularly evident in the peaks observed in the neural recordings. Metastasizing tumors showed discontinuous trains of high neural activity, while non-metastasizing tumors exhibited minimal neural spikes. In simpler terms, the more aggressive tumors had more “active” nerves within them. The presence of sympathetic nerves played a crucial role in this activity. “Sympathectomy, or the chemical removal of sympathetic nerves, eliminated the peak neural activity in both sexes,” noted Dr McCallum, emphasizing the importance of these nerves in tumor progression. “Surprisingly, our research indicates that the brain is not only aware of the presence of a tumor but also establishes lines of communication to control it. The intricate neural activity we observed within melanomas suggests a complex interaction where the brain might influence tumor behavior and progression,” explained Professor Dominique Durand.
In addition to neural recordings, the researchers utilized bioluminescent imaging to track tumor growth and metastasis. By injecting a bioluminescent marker, they were able to visualize the tumors’ expansion and spread to other parts of the body, particularly the cranial area, which is a common site for melanoma metastasis. This method provided a comprehensive view of how the tumors developed and spread over time. The team observed that the neural activity peaks aligned closely with the onset of increased metastatic load, underscoring the potential of neural recordings as a predictive tool.
Additionally, the study found that tumors with low metastatic potential had significantly lower nerve density compared to their highly metastatic counterparts. This difference in nerve density further solidifies the link between neural activity and tumor aggressiveness.
The researchers believe that this study opens new avenues for early diagnosis and targeted therapy in melanoma treatment. “Our findings suggest that monitoring neural activity in tumors could provide a non-invasive method to predict their metastatic potential,” said Professor Durand. “This approach could lead to earlier interventions, potentially improving survival rates for melanoma patients.”
In conclusion, the study by Dr. McCallum, Professor Durand, and their colleagues presents compelling evidence that neural recordings can distinguish between melanomas based on their metastatic potential. This breakthrough not only enhances our understanding of tumor biology but also paves the way for innovative diagnostic tools in cancer treatment.
About the researchers
Journal reference
Shiralkar, J., Anthony, T., McCallum, G. A., & Durand, D. M. (2024). “Neural recordings can differentiate between spontaneously metastasizing melanomas and melanomas with low metastatic potential.” PLOS ONE, 19(2), e0297281. DOI: https://doi.org/10.1371/journal.pone.0297281





